Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Enhanced susceptibility of B lymphoma cells to measles virus by Epstein-Barr virus type III latency that upregulates CD150/signaling lymphocytic activation molecule.

Takeda S, Kanbayashi D, Kurata T, Yoshiyama H, Komano J.

Cancer Sci. 2014 Feb;105(2):211-8. doi: 10.1111/cas.12324. Epub 2014 Jan 12.

2.

Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.

Cohen M, De Matteo E, Narbaitz M, Carreño FA, Preciado MV, Chabay PA.

Int J Cancer. 2013 Apr 1;132(7):1572-80. doi: 10.1002/ijc.27845. Epub 2012 Oct 17.

3.

A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.

Ando M, Sato Y, Takata K, Nomoto J, Nakamura S, Ohshima K, Takeuchi T, Orita Y, Kobayashi Y, Yoshino T.

PLoS One. 2013;8(2):e56741. doi: 10.1371/journal.pone.0056741. Epub 2013 Feb 13.

4.

Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.

Leong IT, Fernandes BJ, Mock D.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):184-93.

PMID:
11505266
5.

Cotton rat (Sigmodon hispidus) signaling lymphocyte activation molecule (CD150) is an entry receptor for measles virus.

Carsillo T, Huey D, Levinsky A, Obojes K, Schneider-Schaulies J, Niewiesk S.

PLoS One. 2014 Oct 8;9(10):e110120. doi: 10.1371/journal.pone.0110120. eCollection 2014.

6.

Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo.

Künzi V, Oberholzer PA, Heinzerling L, Dummer R, Naim HY.

J Invest Dermatol. 2006 Nov;126(11):2525-32. Epub 2006 Sep 7.

7.

Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.

Niedobitek G, Agathanggelou A, Rowe M, Jones EL, Jones DB, Turyaguma P, Oryema J, Wright DH, Young LS.

Blood. 1995 Jul 15;86(2):659-65.

8.

Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.

Sugiyama T, Yoneda M, Kuraishi T, Hattori S, Inoue Y, Sato H, Kai C.

Gene Ther. 2013 Mar;20(3):338-47. doi: 10.1038/gt.2012.44. Epub 2012 Jun 21.

PMID:
22717740
9.

Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.

Pimienta G, Fok V, Haslip M, Nagy M, Takyar S, Steitz JA.

PLoS One. 2015 Jun 29;10(6):e0124638. doi: 10.1371/journal.pone.0124638. eCollection 2015.

10.
11.

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.

Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR, et al.

Eur J Immunol. 1995 May;25(5):1374-84.

PMID:
7774641
13.
14.

EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells.

Boccellato F, Anastasiadou E, Rosato P, Kempkes B, Frati L, Faggioni A, Trivedi P.

J Virol. 2007 Mar;81(5):2274-82. Epub 2006 Dec 6.

15.

CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.

Robertson KD, Manns A, Swinnen LJ, Zong JC, Gulley ML, Ambinder RF.

Blood. 1996 Oct 15;88(8):3129-36.

16.

Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.

Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken HJ, Pallesen G.

Am J Pathol. 1993 Oct;143(4):1072-85.

17.

Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.

Xu WS, Chan AC, Lee JM, Liang RH, Ho FC, Srivastava G.

J Med Virol. 1998 Dec;56(4):342-50.

PMID:
9829640
18.

Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.

Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14935-40. Epub 2006 Sep 25.

20.

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.

Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB.

J Virol. 1992 Jan;66(1):122-31.

Supplemental Content

Support Center